[DISSOCIATED EFFECTS OF A NEW ANTIFIBRINOLYTIC AGENT (EPSILON-AMINOCAPROIC ACID) INJECTED "IN VIVO", ON "IN VITRO" FIBRINOLYSIS TESTS].
D000614:Aminocaproates; D015119:Aminocaproic Acid; D000933:Antifibrinolytic Agents; D001778:Blood Coagulation Disorders; D001780:Blood Coagulation Tests; D005342:Fibrinolysis; D006801:Humans; D066298:In Vitro Techniques; D007267:Injections
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D015119:Aminocaproic Acid
AMINOCAPROIC ACID; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; FIBRINOLYSIS
EFFETS DISOCI'ES D'UN NOUVEL ANTIFIBRINOLYTIQUE (ACIDE EPSILON-AMINO-CAPROUIQUE) INJECT'E "IN VIVO", SUR LES 'EPREUVES "IN VITRO" DE FIBRINOLYSE.